Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,620 | 15,986 | 56,302 | 34,813 | 6,687 |
| Marketable Securities | 46,758 | 55,723 | 17,630 | 46,207 | 50,068 |
| Receivables | 624 | 923 | 903 | N/A | N/A |
| Inventories | 207 | 4,218 | 3,570 | 0 | N/A |
| TOTAL | $62,624 | $79,345 | $80,069 | $81,817 | $58,037 |
| Non-Current Assets | |||||
| PPE Net | 28,204 | 29,777 | 26,343 | 7,457 | 2,441 |
| Investments And Advances | 1,500 | 1,837 | 0 | 1,499 | 1,052 |
| Other Non-Current Assets | 3,486 | 3,065 | 70 | 49 | 46 |
| TOTAL | $33,190 | $34,679 | $26,413 | $9,005 | $3,539 |
| Total Assets | $95,814 | $114,024 | $106,482 | $90,822 | $61,576 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,111 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 145 | 1,256 | 3,576 | 1,439 | 410 |
| Accrued Expenses | 4,815 | 8,324 | 11,605 | 4,588 | 3,457 |
| TOTAL | $6,896 | $10,224 | $15,181 | $6,027 | $3,867 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,502 | 19,265 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,934 | 2,614 | 94 | 115 | 29 |
| TOTAL | $21,436 | $21,879 | $94 | $115 | $29 |
| Total Liabilities | $28,332 | $32,103 | $15,275 | $6,142 | $3,896 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 41,449 | 39,290 | 38,855 | 28,189 | 22,070 |
| Common Shares | 4 | 4 | 3 | 3 | 2 |
| Retained earnings | -244,855 | -223,059 | -161,670 | -111,980 | -81,101 |
| Other shareholders' equity | 12 | 13 | -11 | -31 | -31 |
| TOTAL | $67,482 | $81,921 | $91,207 | $84,680 | $57,680 |
| Total Liabilities And Equity | $95,814 | $114,024 | $106,482 | $90,822 | $61,576 |